Richard William Scalzo
CIK 1789545 · Chief Financial Officer · last filed 2026-09-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
DYN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
HOLLISTON, MA 01746
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Chief Financial Officer | 19,730 | $15.70 | $309.8K | -$30.2K | 3 | 2026-09-18 |
| DYN | SVP, Head of Finance & Admin. | 122,330 | $16.10 | $1.97M | -$8.71M | 35 | 2025-03-13 |
Recent Filings · Page 3 of 7
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-11 | DYN | Sell (S)10b5-1 | −1,468 | -$46.8K | EDGAR |
| 2024-09-10 | DYN | Mixed | −9,596 | -$2.59M | EDGAR |
| 2024-09-06 | DYN | Notice (144) Officer · Planned Aug 19, 2024 Sold: Form 4 filed Sep 10, 2024 |
−126,073 | -$4.24M | EDGAR |
| 2024-08-20 | DYN | Sell (S)10b5-1 Plan adopted Jan 25, 2024 |
−2,752 | -$124.2K | EDGAR |
| 2024-08-19 | DYN | Notice (144) Officer · Planned Aug 19, 2024 Sold: Form 4 filed Aug 20, 2024 |
−2,752 | -$124.2K | EDGAR |
| 2024-06-11 | DYN | Notice (144) Officer · Planned Jun 11, 2024 Sold: Form 4 filed Jun 11, 2024 |
−1,331 | -$41.9K | EDGAR |
| 2024-06-11 | DYN | Sell (S)10b5-1 Plan adopted Jul 11, 2023 |
−2,921 | -$89.8K | EDGAR |
| 2024-06-10 | DYN | Notice (144) Officer · Planned Jun 10, 2024 · 10b5-1 plan Sold: Form 4 filed Jun 11, 2024 |
−1,590 | -$48.1K | EDGAR |
| 2024-05-17 | DYN | Sell (S)10b5-1 Plan adopted Jan 25, 2024 |
−2,588 | -$73.2K | EDGAR |
| 2024-05-16 | DYN | Notice (144) Officer · Planned May 16, 2024 Sold: Form 4 filed May 17, 2024 |
−2,589 | -$73.2K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
2 sales · $41.5K| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2025-06-05 | DYN Seller: Rick Scalzo |
914 | $12.2K | $13.35 | 2025-06-11 |
| 2025-05-16 | DYN | 2,479 | $29.3K | $11.82 | 2025-06-05 |